Prescription Drugs - Qatar

  • Qatar
  • The Prescription Drugs market in Qatar is expected to experience significant growth in the coming years.
  • According to projections, revenue is set to reach QAR US$0.61bn by 2024.
  • This positive trend is expected to continue, with an annual growth rate (CAGR 2024-2029) of 4.22%.
  • As a result, the market volume is projected to reach QAR US$0.75bn by 2029.
  • When compared to other countries globally, United States is anticipated to generate the highest revenue in the Prescription Drugs market, reaching a staggering QAR US$358.90bn by 2024.
  • This highlights the significant role United States plays in this market.
  • In terms of per capita figures, in Qatar is expected to generate revenue of QAR US$224.10 per person in 2024.
  • This indicates the level of spending on Prescription Drugs market within the country's population.
  • The prescription drug market in Qatar is experiencing a surge in demand for specialized medications due to the country's growing elderly population.

Key regions: Japan, China, Europe, Australia, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Prescription Drugs (Pharmacies) market in Qatar has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in Qatar have played a crucial role in the growth of the Prescription Drugs (Pharmacies) market. Qatar has a high demand for prescription drugs due to the country's rapidly growing population and increasing healthcare needs. Customers in Qatar prefer convenient access to prescription drugs, and pharmacies provide a convenient and accessible option for them. Additionally, customers in Qatar value high-quality healthcare services, and pharmacies in the country strive to meet these expectations by providing a wide range of prescription drugs and personalized services. Several trends have emerged in the Prescription Drugs (Pharmacies) market in Qatar. One notable trend is the increasing adoption of digital technologies in pharmacies. Many pharmacies in Qatar have embraced digital platforms to streamline their operations and enhance customer experience. This includes online ordering and home delivery services, as well as digital health platforms that provide information and resources to customers. The use of digital technologies has not only improved convenience for customers but also increased efficiency and productivity for pharmacies. Another trend in the market is the growing focus on preventive healthcare. Qatar has been investing heavily in healthcare infrastructure and initiatives to promote preventive healthcare. This includes campaigns and programs to raise awareness about the importance of regular check-ups, vaccinations, and early detection of diseases. Pharmacies in Qatar play a vital role in these initiatives by providing access to prescription drugs that promote preventive healthcare, such as vaccines and preventive medications. Local special circumstances in Qatar have also contributed to the development of the Prescription Drugs (Pharmacies) market. Qatar has a high prevalence of chronic diseases, such as diabetes and cardiovascular diseases. This has led to an increased demand for prescription drugs to manage these conditions. Pharmacies in Qatar have responded to this demand by expanding their product offerings and providing specialized services for chronic disease management. Underlying macroeconomic factors have also influenced the growth of the Prescription Drugs (Pharmacies) market in Qatar. The country has a strong economy and high per capita income, which has increased the affordability of prescription drugs for the population. Additionally, Qatar has a robust healthcare system and a government that prioritizes healthcare investments. This has created a favorable environment for the development and expansion of pharmacies in the country. In conclusion, the Prescription Drugs (Pharmacies) market in Qatar has experienced significant growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The convenience and accessibility provided by pharmacies, along with the adoption of digital technologies, have contributed to the market's expansion. The focus on preventive healthcare and the high prevalence of chronic diseases in Qatar have also driven the demand for prescription drugs. The country's strong economy and supportive healthcare system have further facilitated the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)